Browsing Pharmacy and Pharmaceutical Sciences (Scholarly Publications) by Author "O'DRISCOLL, LORRAINE"
Now showing items 1-20 of 61
-
Biomarkers and multiple drug resistance in breast cancer.
O'DRISCOLL, LORRAINE (2006) -
Challenges in molecular analysis for individualized cancer therapy.
O'DRISCOLL, LORRAINE (2003) -
Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
RANI, SWETA; O'DRISCOLL, LORRAINE (2011)Background: There is no effective treatment strategy for advanced castration-resistant prostate cancer. Although Docetaxel (Taxotere?) represents the most active chemotherapeutic agent it only gives a modest survival ... -
Characterisation of BHK-21 cells engineered to secrete human insulin
O'DRISCOLL, LORRAINE (2003) -
Current Cancer Drug Targets
O'DRISCOLL, LORRAINE (Bentham Science Publishers Ltd., 2009) -
Detecting de novo insulin synthesis in embryonic stem cell-derived populations.
O'DRISCOLL, LORRAINE (2007) -
Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes.
CORCORAN, CLAIRE; O'DRISCOLL, LORRAINE (2012)Background Hormone-refractory prostate cancer remains hindered by inevitable progression of resistance to first-line treatment with docetaxel. Recent studies suggest that phenotypic changes associated with cancer may ... -
Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue.
O'DRISCOLL, LORRAINE (2008) -
Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents.
O'DRISCOLL, LORRAINE (2007) -
The emerging world of microRNAs.
O'DRISCOLL, LORRAINE (2006) -
Engineering Vero cells to secrete human insulin
O'DRISCOLL, LORRAINE (2002) -
Expression and prognostic relevance of Mcl-1 in breast cancer.
O'DRISCOLL, LORRAINE (2004) -
Expression in murine teratocarcinoma F9 cells of transcription factors involved in pancreas development.
O'DRISCOLL, LORRAINE (2004)